World's Best Scientists 2026 revealed!
Riichiro Abe

Riichiro Abe

D-Index & Metrics

Biology and Biochemistry

D-Index
54
Citations
11850
World Ranking
15531
National Ranking
1102

Riichiro Abe publication distribution in Biology and Biochemistry in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Biology and Biochemistry in 2026. The highlighted bar marks where Riichiro Abe sits on this spectrum.

47–56 publications: 8 scientists 57–66 publications: 35 scientists 67–76 publications: 106 scientists 77–86 publications: 231 scientists 87–96 publications: 414 scientists 97–106 publications: 546 scientists 107–116 publications: 704 scientists 117–126 publications: 849 scientists 127–136 publications: 980 scientists 137–146 publications: 942 scientists 147–156 publications: 969 scientists 157–166 publications: 950 scientists 167–176 publications: 951 scientists 177–186 publications: 915 scientists 187–196 publications: 787 scientists 197–206 publications: 841 scientists 207–216 publications: 735 scientists 217–226 publications: 709 scientists 227–236 publications: 651 scientists 237–246 publications: 605 scientists 247–256 publications: 510 scientists 257–266 publications: 524 scientists 267–276 publications: 434 scientists 277–286 publications: 418 scientists 287–296 publications: 350 scientists 297–306 publications: 363 scientists 307–316 publications: 315 scientists 317–326 publications: 296 scientists 327–336 publications: 261 scientists 337–346 publications: 240 scientists 347–356 publications: 219 scientists 357–366 publications: 197 scientists 367–376 publications: 154 scientists 377–386 publications: 161 scientists 387–396 publications: 155 scientists 397–406 publications: 145 scientists 407–416 publications: 124 scientists 417–426 publications: 112 scientists 427–436 publications: 132 scientists 437–446 publications: 116 scientists 447–456 publications: 99 scientists 457–466 publications: 81 scientists 467–476 publications: 91 scientists 477–486 publications: 80 scientists 487–496 publications: 80 scientists 497–506 publications: 60 scientists 507–516 publications: 36 scientists 517–526 publications: 46 scientists 527–536 publications: 54 scientists 537–546 publications: 44 scientists 547–556 publications: 43 scientists 557–566 publications: 43 scientists 567–576 publications: 42 scientists 577–586 publications: 25 scientists 587–596 publications: 34 scientists 597–606 publications: 23 scientists 607–616 publications: 33 scientists 617–626 publications: 31 scientists 627–636 publications: 27 scientists 637–646 publications: 25 scientists 647–656 publications: 28 scientists 657–666 publications: 34 scientists 667–676 publications: 18 scientists 677–686 publications: 16 scientists 687–696 publications: 10 scientists 697–706 publications: 12 scientists 707–716 publications: 21 scientists 717–726 publications: 12 scientists 727–736 publications: 12 scientists 737–746 publications: 10 scientists 747–756 publications: 7 scientists 757–766 publications: 13 scientists 767–776 publications: 15 scientists 777–786 publications: 13 scientists 787–796 publications: 9 scientists 797–806 publications: 9 scientists 807–816 publications: 7 scientists 817–826 publications: 4 scientists 827–836 publications: 9 scientists 837–846 publications: 7 scientists 847–856 publications: 3 scientists 857–866 publications: 5 scientists 867–876 publications: 5 scientists 877–886 publications: 11 scientists 887–896 publications: 3 scientists 897–906 publications: 4 scientists 907–916 publications: 7 scientists 917–926 publications: 5 scientists 927–936 publications: 6 scientists 937–946 publications: 6 scientists 947–956 publications: 3 scientists 957–966 publications: 7 scientists 967–976 publications: 2 scientists 977–986 publications: 2 scientists 987–996 publications: 1 scientists 997–1,006 publications: 5 scientists 1,007–1,016 publications: 2 scientists 1,017–1,026 publications: 2 scientists 1,027 publications: 1 scientists 1,028+ publications: 100 scientists
47 publications 1,028+

This scientist: 315 publications — 81st percentile

81% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 1,028 publications or more.

Riichiro Abe D-index placement in Biology and Biochemistry in 2026

The chart shows the D-index (discipline H-index) distribution of Biology and Biochemistry scientists ranked by Research.com in 2026. The highlighted bar marks where Riichiro Abe sits on this spectrum.

40–41 D-Index: 80 scientists 42–43 D-Index: 183 scientists 44–45 D-Index: 317 scientists 46–47 D-Index: 504 scientists 48–49 D-Index: 718 scientists 50–51 D-Index: 900 scientists 52–53 D-Index: 1,026 scientists 54–55 D-Index: 1,150 scientists 56–57 D-Index: 1,236 scientists 58–59 D-Index: 1,253 scientists 60–61 D-Index: 1,163 scientists 62–63 D-Index: 1,131 scientists 64–65 D-Index: 1,032 scientists 66–67 D-Index: 897 scientists 68–69 D-Index: 814 scientists 70–71 D-Index: 715 scientists 72–73 D-Index: 709 scientists 74–75 D-Index: 596 scientists 76–77 D-Index: 512 scientists 78–79 D-Index: 473 scientists 80–81 D-Index: 412 scientists 82–83 D-Index: 373 scientists 84–85 D-Index: 358 scientists 86–87 D-Index: 285 scientists 88–89 D-Index: 273 scientists 90–91 D-Index: 227 scientists 92–93 D-Index: 208 scientists 94–95 D-Index: 193 scientists 96–97 D-Index: 153 scientists 98–99 D-Index: 157 scientists 100–101 D-Index: 148 scientists 102–103 D-Index: 120 scientists 104–105 D-Index: 113 scientists 106–107 D-Index: 100 scientists 108–109 D-Index: 86 scientists 110–111 D-Index: 67 scientists 112–113 D-Index: 72 scientists 114–115 D-Index: 73 scientists 116–117 D-Index: 64 scientists 118–119 D-Index: 53 scientists 120–121 D-Index: 60 scientists 122–123 D-Index: 54 scientists 124–125 D-Index: 43 scientists 126–127 D-Index: 38 scientists 128–129 D-Index: 49 scientists 130–131 D-Index: 26 scientists 132–133 D-Index: 18 scientists 134–135 D-Index: 23 scientists 136–137 D-Index: 32 scientists 138–139 D-Index: 32 scientists 140–141 D-Index: 27 scientists 142–143 D-Index: 19 scientists 144–145 D-Index: 22 scientists 146–147 D-Index: 12 scientists 148–149 D-Index: 16 scientists 150–151 D-Index: 14 scientists 152–153 D-Index: 10 scientists 154–155 D-Index: 13 scientists 156–157 D-Index: 10 scientists 158–159 D-Index: 7 scientists 160–161 D-Index: 9 scientists 162–163 D-Index: 13 scientists 164–165 D-Index: 4 scientists 166 D-Index: 4 scientists 167+ D-Index: 98 scientists
40 D-Index 167+

This scientist: 54 D-Index — 22nd percentile

22% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 167 D-Index or more.

Overview

Riichiro Abe is affiliated with Niigata University in Japan and has contributed extensively to the field of medicine with a particular focus on pharmacology, dermatology, pathology and forensic medicine, rheumatology, and epidemiology. Their research encompasses various subfields emphasizing the mechanisms and clinical aspects of drug-induced adverse reactions and autoimmune skin diseases.

The scientist's body of work includes studies on drug-induced adverse reactions, autoimmune bullous skin diseases, urticaria, cutaneous lymphoproliferative disorders, dermatology and skin diseases, skin and cellular biology research, and contact dermatitis and allergies.

Frequent coauthors collaborating with Riichiro Abe include Ryota Hayashi, Akito Hasegawa, Natsumi Hama, Satoru Shinkuma, and Masashi Akiyama, reflecting a collaborative research environment.

Riichiro Abe has published numerous papers in renowned journals and professional venues. Notable recent publications include:

  • "Recent advances in managing and understanding Stevens-Johnson syndrome and toxic epidermal necrolysis," 2020, F1000Research
  • "Drug-Induced Hypersensitivity Syndrome (DIHS)/Drug Reaction With Eosinophilia and Systemic Symptoms (DRESS): Clinical Features and Pathogenesis," 2022, The Journal of Allergy and Clinical Immunology In Practice
  • "Spatial proteomics identifies JAKi as treatment for a lethal skin disease," 2024, Nature
  • "Neutrophils initiate and exacerbate Stevens-Johnson syndrome and toxic epidermal necrolysis," 2021, Science Translational Medicine
  • "SJS/TEN 2019: From science to translation," 2020, Journal of Dermatological Science

The majority of Riichiro Abe's publications appear in specialized dermatology and related journals. Frequent publication venues include:

  • The Journal of Dermatology
  • Journal of the European Academy of Dermatology and Venereology
  • Faculty Opinions - Post-Publication Peer Review of the Biomedical Literature
  • Journal of Investigative Dermatology
  • Journal of Dermatological Science

Their research contributes to a more detailed understanding of clinical and pathophysiological aspects of various dermatological conditions, especially those triggered by drugs or involving immune system dysregulation.

Best Publications

  • Peripheral blood fibrocytes differentiation pathway and migration to wound sites

    Riichiro Abe;Richard Bucala;Seamas Donnelly;Christine Metz

  • Mesenchymal Stem Cells Are Recruited into Wounded Skin and Contribute to Wound Repair by Transdifferentiation into Multiple Skin Cell Type

    Mikako Sasaki;Riichiro Abe;Yasuyuki Fujita;Satomi Ando

  • Fibrocytes induce an angiogenic phenotype in cultured endothelial cells and promote angiogenesis in vivo

    Ingo Hartlapp;Riichiro Abe;Rubina W. Saeed;Tina Peng

  • Toxic epidermal necrolysis and Stevens-Johnson syndrome are induced by soluble Fas ligand

    Riichiro Abe;Tadamichi Shimizu;Akihiko Shibaki;Hideki Nakamura

  • Angiogenesis induced by advanced glycation end products and its prevention by cerivastatin

    Tamami Okamoto;Sho ichi Yamagishi;Yosuke Inagaki;Shinjiro Amano

  • High Expression of Macrophage Migration Inhibitory Factor in Human Melanoma Cells and Its Role in Tumor Cell Growth and Angiogenesis

    Tadamichi Shimizu;Riichiro Abe;Hideki Nakamura;Akira Ohkawara

  • A Novel Polymorphic CAAT/Enhancer-Binding Protein β Element in the FasL Gene Promoter Alters Fas Ligand Expression: A Candidate Background Gene in African American Systemic Lupus Erythematosus Patients

    Jianming Wu;Christine Metz;Xiulong Xu;Riichiro Abe

  • Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes.

    An Chi;Julio C. Valencia;Zhang Zhi Hu;Hidenori Watabe

  • Regulation of Human Melanoma Growth and Metastasis by AGE–AGE Receptor Interactions

    Riichiro Abe;Tadamichi Shimizu;Hiroshi Sugawara;Hirokazu Watanabe

  • Regulation of the ctl response by macrophage migration inhibitory factor

    Riichiro Abe;Richard Bucala;Christine Metz

  • AGE-RAGE System and Carcinogenesis

    Riichiro Abe;Sho-ichi Yamagishi

  • Lupus erythematosus panniculitis (lupus profundus): clinical, histopathological, and molecular analysis of nine cases.

    Cesare Massone;Kazuo Kodama;Kazuo Kodama;Wolfgang Salmhofer;Riichiro Abe

  • Overexpression of pigment epithelium-derived factor decreases angiogenesis and inhibits the growth of human malignant melanoma cells in vivo.

    Riichiro Abe;Tadamichi Shimizu;Sho-ichi Yamagishi;Akihiko Shibaki

  • Pigment epithelium-derived factor inhibits TNF-α-induced interleukin-6 expression in endothelial cells by suppressing NADPH oxidase-mediated reactive oxygen species generation

    Sho Ichi Yamagishi;Yosuke Inagaki;Kazuo Nakamura;Riichiro Abe

  • An Updated Review of the Molecular Mechanisms in Drug Hypersensitivity.

    Chun-Bing Chen;Riichiro Abe;Ren-You Pan;Ren-You Pan;Chuang-Wei Wang;Chuang-Wei Wang

  • SJS/TEN 2017: Building Multidisciplinary Networks to Drive Science and Translation

    Katie D. White;Riichiro Abe;Michael Ardern-Jones;Thomas Beachkofsky

  • Enhancement of macrophage migration inhibitory factor (MIF) expression in injured epidermis and cultured fibroblasts

    Riichiro Abe;Tadamichi Shimizu;Akira Ohkawara;Jun Nishihira

  • An annexin A1–FPR1 interaction contributes to necroptosis of keratinocytes in severe cutaneous adverse drug reactions

    Nao Saito;Hongjiang Qiao;Teruki Yanagi;Satoru Shinkuma

  • Sequelae in 145 patients with drug-induced hypersensitivity syndrome/drug reaction with eosinophilia and systemic symptoms: survey conducted by the Asian Research Committee on Severe Cutaneous Adverse Reactions (ASCAR).

    Yoko Kano;Mikiko Tohyama;Michiko Aihara;Setsuko Matsukura

  • Granulysin as a Marker for Early Diagnosis of the Stevens–Johnson Syndrome

    Riichiro Abe;Naoya Yoshioka;Junko Murata;Yasuyuki Fujita

Frequent Co-Authors

Hiroshi Shimizu
Hiroshi Shimizu Hokkaido University
Masashi Akiyama
Masashi Akiyama Nagoya University
Sho-ichi Yamagishi
Sho-ichi Yamagishi Kurume University
Jun Nishihira
Jun Nishihira Hokkaido University
Christine N. Metz
Christine N. Metz Feinstein Institute for Medical Research
Richard Bucala
Richard Bucala Yale University
Gang Wang
Gang Wang Xijing Hospital
Masatsugu Shimomura
Masatsugu Shimomura Tohoku University
Hironobu Ihn
Hironobu Ihn Kumamoto University
Elizabeth J. Phillips
Elizabeth J. Phillips Vanderbilt University Medical Center

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Pursuing a degree in Biology or Biochemistry opens doors to diverse career paths, especially in today’s rapidly evolving healthcare landscape. For those interested in blending scientific expertise with leadership, an affordable online MBA healthcare management program can be an attractive option, providing skills to manage teams or entire departments in healthcare organizations.

Another popular direction is the field of medical coding and billing. Understanding the difference between cpc certification and other credentials is key for those looking to enter this sector. Certified coders are in high demand, and can expect steady job prospects and competitive salaries.

Wondering how much do medical coders make? Salaries vary by location, certification, and experience, but this role often provides flexibility and the opportunity to work remotely. With the healthcare industry’s ongoing digitization, you may be curious—is medical billing and coding in demand? The answer is yes, making it a stable and rewarding option for science graduates.

Best Scientists Citing Riichiro Abe

Trending Scientists

Recently Published Articles